STOCK TITAN

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, May 13, 2026 at 10:00 a.m. PT.

(Neutral)
(Very Positive)
Tags

Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, May 13, 2026 at 10:00 a.m. PT. Presenters are Peter Griffith (EVP & CFO) and Jay Bradner (EVP, R&D). The presentation will be webcast and archived for at least 90 days.

Webcast access, timing and links are available on Amgen's Investor Relations Events Calendar on the company website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus May 8 session
+0.79% close to close Open Argus
Details

News Market Reaction – AMGN

On May 8, the first trading day after this news, AMGN closed 0.79% above the previous close.

Data tracked by StockTitan Argus for the May 8 session.

Market Context

This announcement highlights Amgen’s upcoming presentation at a major healthcare conference, offerin...
Analysis

This announcement highlights Amgen’s upcoming presentation at a major healthcare conference, offering investors live and archived webcast access for at least 90 days. It follows recent earnings, manufacturing investment news, and organizational updates that shaped the company’s near‑term narrative. With an automatic shelf registration in place and recent insider Form 4 activity, investors may focus on management’s strategic and financial commentary during the conference rather than this scheduling news itself.

Key Figures

Conference time: 10:00 a.m. PT Conference date: May 13, 2026 Webcast archive period: at least 90 days
Conference time
10:00 a.m. PT
Scheduled presentation at Bank of America Merrill Lynch Global Healthcare Conference
Conference date
May 13, 2026
Date of Amgen’s presentation at the conference
Webcast archive period
at least 90 days
Length of time the conference webcast will be available for replay

Historical Context

5 past events · Latest: May 04
5 events
  1. May 04

    Manufacturing investment

    24h Move
    -1.8%

    Announced additional U.S. biologics manufacturing investment totaling nearly $2B over year.

  2. Apr 30

    Earnings correction

    24h Move
    -4.8%

    Clarified Q1 2026 revenues, EPS and guidance details following initial earnings release.

  3. Apr 30

    Q1 2026 earnings

    24h Move
    -4.8%

    Reported Q1 revenue growth, EPS increases, strong margins and full‑year 2026 guidance.

  4. Apr 24

    Earnings webcast

    24h Move
    -1.3%

    Announced timing and webcast details for the first quarter 2026 financial results call.

  5. Apr 22

    Management change

    24h Move
    +0.8%

    Announced CTO retirement and organizational changes integrating biology, data science and AI.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

webcast
1 terms
webcast technical
"The webcast will be broadcast over the internet simultaneously and will be available..."
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

THOUSAND OAKS, Calif., May 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m. PT on Wednesday, May 13, 2026. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Casey Capparelli, 805-447-1746 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-bank-of-america-merrill-lynch-global-healthcare-conference-302766201.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen (AMGN) present at the Bank of America Merrill Lynch Global Healthcare Conference?

Amgen will present on Wednesday, May 13, 2026 at 10:00 a.m. PT. According to the company, the session features Amgen executives and will be available via live webcast to investors, media and the public, with archived replay for at least 90 days.

Who will present for Amgen (AMGN) at the May 13, 2026 conference?

Presenters are Peter Griffith, EVP and CFO, and Jay Bradner, EVP of Research and Development. According to the company, both executives will deliver the presentation and participate in the webcast available to investors and the public.

How can investors watch Amgen's (AMGN) webcast from the May 13, 2026 conference?

Investors can watch the live webcast on Amgen's website under Investors > Events. According to the company, webcast links and timing are listed on its Investor Relations Events Calendar and the presentation will be archived for replay.

Will Amgen's (AMGN) May 13, 2026 conference webcast be available after the event?

Yes. The webcast will be archived and available for replay for at least 90 days after the event. According to the company, archived access will be posted on Amgen's Investor Relations site for media, investors and the public.

Keep reading